Navigation Links
GenturaDx Appoints Senior Vice President of Research & Development
Date:7/11/2011

HAYWARD, Calif., July 11, 2011 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced today that Geoffrey A. McKinley, Ph.D., has joined the company as Senior Vice President of Research & Development.  McKinley joins as GenturaDx accelerates research to bring its IDbox™ System to commercialization.

(Photo:  http://photos.prnewswire.com/prnh/20110711/LA32940)

"With his depth of experience developing molecular diagnostic products, Geoff will be a key asset in commercializing our molecular platform in the next 12 to 24 months," said Mark Bagnall, GenturaDx's chief executive officer. "GenturaDx anticipates completing beta studies this year and clinical studies in 2012, and Geoff is an important addition to a talented R & D team working to perfect our system as well as develop partnerships with companies that seek to adapt assay content to our platform."

Dr. McKinley brings to GenturaDx nearly two decades of research & development and business development experience related to developing molecular diagnostic products and tools for infectious diseases.  Prior to joining GenturaDx, Dr. McKinley was responsible for research & development to support molecular biology assay, consumable and instrumentation development at Osmetech, Inc. He has previously held positions at Naxcor, Inc., BioMerieux, Inc., and Analytab Products, a division of Sherwood Medical. Dr. McKinley earned his Ph.D. at Colorado State University.

"It's a great time to be at GenturaDx," Dr. McKinley said, "because its unique, PCR-based, sample-to-answer IDbox System has the potential to dramatically impact molecular diagnostics, offering potential performance advantages over existing systems on the market and making the molecular testing affordable and easy to use for the estimated 5,000 small-to-medium sized hospitals that rely on traditional culture techniques or immunoassay testing."

About GenturaDx

GenturaDx is a molecular diagnostic company focused on making molecular diagnostics both affordable and practical for any laboratory to perform.  The company's IDbox System incorporates all aspects of proprietary, real-time PCR testing from sample preparation through result generation in a single-use cassette. This platform will make rapid, high-quality molecular diagnostics accessible to hospitals and patients worldwide – circumventing long-standing barriers of costs, automation and performance. GenturaDx's compact, self-contained platform reduces the risk of contamination and saves time; the platform's unique engineering design and intuitive interface relies on semi-batch processing capability while improving clinical value by offering multiple molecular targets in a single test.


'/>"/>
SOURCE GenturaDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Pa. , Oct. 12, 2017 ... leader in innovative solutions for injectable drug administration, today ... before the market opens on Thursday, October 26, 2017, ... the results and business expectations at 9:00 a.m. Eastern ... (U.S.) or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):